I agree. A downgrade seems inevitable now.
UK continues to be decimated by COVID, so access to potential customers remains low. In this uncertain environment, Customer appetite to rip apart their technology stack and spend 2-3 years to implement Bravura's tech is low or non-existent.
- Forums
- ASX - By Stock
- Ann: CFO Transition
BVS
bravura solutions limited.
Add to My Watchlist
0.45%
!
$2.23

I agree. A downgrade seems inevitable now.UK continues to be...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.23 |
Change
-0.010(0.45%) |
Mkt cap ! $999.8M |
Open | High | Low | Value | Volume |
$2.22 | $2.30 | $2.20 | $2.136M | 953.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7286 | $2.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.25 | 64114 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7286 | 2.230 |
2 | 28982 | 2.220 |
1 | 5082 | 2.210 |
1 | 10000 | 2.200 |
2 | 2250 | 2.180 |
Price($) | Vol. | No. |
---|---|---|
2.250 | 64114 | 1 |
2.260 | 14909 | 2 |
2.360 | 13283 | 1 |
2.400 | 1086 | 1 |
2.500 | 100204 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online